Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia
Clinical trial NCT05621070 · RECRUITING
Trial details
- NCT number
- NCT05621070
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-03
- Primary completion
- 2024-09-23
- Enrollment
- 582
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.